Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma

BACKGROUND: We previously reported early on-treatment significant modulation in circulating regulatory T cell (Treg), myeloid derived suppressor cells (MDSC) and antigen-specific type I CD4+ and CD8+ T cells that correlated with clinical outcome in regionally advanced melanoma patients treated with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Transl Med
Main Authors: Retseck, Janet, Nasr, Alexis, Lin, Yan, Lin, Huang, Mendiratta, Prateek, Butterfield, Lisa H., Tarhini, Ahmad A.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033230/
https://ncbi.nlm.nih.gov/pubmed/29973204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1563-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki